Effects of PFOA Exposure during Pregnancy in the Mouse

There are more than 7 million PFAS and over 21 million fluorinated compounds listed in PubChem (2023).
Post Reply
admin
Site Admin
Posts: 5491
Joined: Tue Jan 18, 2005 10:25 pm

Effects of PFOA Exposure during Pregnancy in the Mouse

Post by admin »

First Posted: 02 Mar 2006 08:08 am


"Effects of Perfluorooctanoic Acid Exposure during Pregnancy in the Mouse"

Lau C, Thibodeaux JR, Hanson RG, Narotsky MG, Rogers JM, Lindstrom AB, Strynar MJ - "Effects of Perfluorooctanoic Acid Exposure during Pregnancy in the Mouse" Toxicol Sci. 2006 Jan 16;


Perfluorooctanoic acid (PFOA), a member of the perfluoroalkyl acids that have wide commercial applications, has recently been detected in humans and wildlife. The current study characterizes the developmental toxicity of PFOA in the mouse. Timed pregnant CD-1 mice were given 1, 3, 5, 10, 20 or 40 mg/kg PFOA by oral gavage daily from gestational day (GD) 1 to 17; controls received an equivalent volume (10 ml/kg) of water. PFOA treatment produced dose-dependent full-litter resorptions; all dams in the 40 mg/kg group resorbed their litters. Weight gain in dams that carried pregnancy to term was significantly lower in the 20 mg/kg group. At GD 18, some dams were sacrificed for maternal and fetal examinations
(group A), and the rest were treated once more with PFOA and allowed to give birth (group B). Postnatal survival, growth and development of the offspring were monitored. PFOA induced enlarged liver in group A dams at all dosages, but did not alter the number of implantations. The percent of live fetuses was lower only in the 20 mg/kg group (74% vs. 94% in controls), and fetal weight was also significantly lower in this group. However, no significant increase in malformations was noted in any treatment group. The incidence of live birth in group B mice was significantly lowered by PFOA: ca. 70% for the 10 and 20 mg/kg groups compared to 96% for controls. Postnatal survival was severely compromised at 10 or 20 mg/kg, and moderately so at 5 mg/kg. Dose-dependent growth deficits were detected in all PFOA-treated litters except the 1 mg/kg group. Significant delays in eye-opening (up to 2-3 days) were noted at 5 mg/kg and higher dosages. Accelerated sexual maturation was observed in male offspring, but not in females. These data indicate maternal and developmental toxicity of PFOA in the mouse, leading to early pregnancy loss, compromised postnatal survival, delays in general growth and development, and sex-specific alterations in pubertal maturation.

PMID: 16415327
Post Reply